Tips for Raw Materials & Excipients Management

Symptoms of impurity profile drift can often surface unexpectedly during routine quality control testing or through unexpected deviations reported by manufacturing teams. Common symptoms include:Click to read the full article.

Addressing API Assay Variability Beyond Trend Limits During a Deviation Investigation In pharmaceutical manufacturing, effective management of Active Pharmaceutical Ingredients (APIs) is crucial to maintaining product quality and regulatory compliance.…

In any pharmaceutical manufacturing setting, recognizing the symptoms of API assay variability is critical for timely intervention. Symptoms may manifest as:Click to read the full article.

Symptoms of impurity profile drift can manifest in various ways during the production process. Early detection is crucial for mitigating risks, and various signs should be monitored closely:Click to read…

Investigation of API Stability Failures During Stability Studies: Ensuring Compliance with GMP Expectations The pharmaceutical landscape is fraught with challenges around material quality, particularly concerning active pharmaceutical ingredients (API) during…

The first step in addressing particle size variability is to recognize clear signals or symptoms that may indicate a deviation from expected performance. Typical symptoms might include:Click to read the…

Investigating Impurity Profile Drift in Pharmaceutical Manufacturing: A Comprehensive Approach Detecting impurity profile drift during a deviation investigation can pose significant challenges for pharmaceutical manufacturers. This scenario raises critical questions…

Symptoms of impurity profile drift may arise during various stages of production, testing, and stability assessment. Key indicators include:Click to read the full article.

Recognizing the symptoms of impurity profile drift is the first step in initiating a thorough investigation. In a laboratory or manufacturing setting, this could manifest in various ways:Click to read…

The initial step in addressing impurity profile drift is recognizing the symptoms that manifest during manufacturing. These symptoms may become apparent through routine testing or during specific investigations of unexpected…

Identifying the symptoms associated with API assay variability is the first step in any investigation. Common signals that reveal issues during the incoming testing phase may include:Click to read the…

Identifying the signals of impurity profile drift is the first step in ensuring compliance with the stringent regulations set by authorities like the FDA and EMA. Symptoms may include:Click to…